Skip to main content

An official website of the United States government

You have 2 new alerts

A--PREVENT IDIQ MATO RFP

Award Details

  • Contract Award Date: Jan 24, 2024
  • Contract Award Number: 75N91024D00004
  • Task/Delivery Order Number:
  • Contractor Awarded Unique Entity ID: S3GMKS8ELA16
  • Contractor Awarded Name: THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM
  • Contractor Awarded Address: Houston, TX 77030 USA
  • Base and All Options Value (Total Contract Value): $149,995,000.00

General Information

  • Contract Opportunity Type: Award Notice (Updated)
  • Updated Published Date: Jan 31, 2024 04:51 pm EST
  • Original Published Date: Jan 29, 2024 09:43 am EST
  • Inactive Policy: 15 days after contract award date
  • Updated Inactive Date: Feb 08, 2024
  • Original Inactive Date: Feb 07, 2024
  • Initiative:
    • None

Classification

  • Original Set Aside:
  • Product Service Code:
  • NAICS Code:
    • 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
  • Place of Performance:
    Houston , TX 77030
    USA

Description

PREVENT EFFICACY Pool: This contract supports the PREVENT Cancer Preclinical Drug Development Program,
which provides a structured approach to drug and vaccine development, from discovery to the clinic. This contract is a
part of a multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) pool to procure services related to Preclinical
Efficacy and Intermediate Endpoint Biomarkers, which is also referred to as the Efficacy Pool.

Contact Information

Contracting Office Address

  • OFFICE OF ACQUISITIONS 31Center Dr. 11A35P
  • Bethesda , MD 20892
  • USA

Primary Point of Contact

Secondary Point of Contact





History